A detailed history of Nwk Group, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Nwk Group, Inc. holds 74,153 shares of BSX stock, worth $6.75 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares
74,153
Previous 74,871 0.96%
Holding current value
$6.75 Million
Previous $5.77 Million 7.79%
% of portfolio
2.56%
Previous 2.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $52,385 - $60,312
-718 Reduced 0.96%
74,153 $6.21 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $12,456 - $14,376
185 Added 0.25%
74,871 $5.77 Million
Q1 2024

May 10, 2024

BUY
$57.6 - $68.62 $100,108 - $119,261
1,738 Added 2.38%
74,686 $5.12 Million
Q4 2023

Feb 12, 2024

BUY
$48.64 - $57.81 $3.55 Million - $4.22 Million
72,948 New
72,948 $4.22 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Nwk Group, Inc. Portfolio

Follow Nwk Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nwk Group, Inc. with notifications on news.